TW200744625A - HCV inhibitors - Google Patents

HCV inhibitors

Info

Publication number
TW200744625A
TW200744625A TW095123601A TW95123601A TW200744625A TW 200744625 A TW200744625 A TW 200744625A TW 095123601 A TW095123601 A TW 095123601A TW 95123601 A TW95123601 A TW 95123601A TW 200744625 A TW200744625 A TW 200744625A
Authority
TW
Taiwan
Prior art keywords
compounds
present
hcv inhibitors
directed
hcv
Prior art date
Application number
TW095123601A
Other languages
Chinese (zh)
Other versions
TWI449711B (en
Inventor
Michael Graupe
John O Link
Chandrasekar Venkataramani
Original Assignee
Virobay Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virobay Inc filed Critical Virobay Inc
Publication of TW200744625A publication Critical patent/TW200744625A/en
Application granted granted Critical
Publication of TWI449711B publication Critical patent/TWI449711B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating hepatitis C infections. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
TW095123601A 2005-06-30 2006-06-29 Hcv inhibitors TWI449711B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69576705P 2005-06-30 2005-06-30

Publications (2)

Publication Number Publication Date
TW200744625A true TW200744625A (en) 2007-12-16
TWI449711B TWI449711B (en) 2014-08-21

Family

ID=39933853

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095123601A TWI449711B (en) 2005-06-30 2006-06-29 Hcv inhibitors

Country Status (3)

Country Link
CN (1) CN101242816B (en)
TW (1) TWI449711B (en)
ZA (1) ZA200711069B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102413079B1 (en) * 2014-05-28 2022-06-24 어젠시스 인코포레이티드 Derivatives of dolaproine-dolaisoleuine peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1136498A1 (en) * 1996-10-18 2001-09-26 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases, particularly hepatitis c virus NS3 protease
US6323180B1 (en) * 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
CN102372764A (en) * 2000-07-21 2012-03-14 先灵公司 Novel peptides as NS3-serine protease inhibitors of hepatitis c virus
KR101115294B1 (en) * 2003-05-21 2012-04-12 베링거 인겔하임 인터내셔날 게엠베하 Hepatitis C inhibitor compounds
MY148123A (en) * 2003-09-05 2013-02-28 Vertex Pharma Inhibitors of serine proteases, particularly hcv ns3-ns4a protease

Also Published As

Publication number Publication date
TWI449711B (en) 2014-08-21
CN101242816B (en) 2012-10-31
CN101242816A (en) 2008-08-13
ZA200711069B (en) 2009-03-25

Similar Documents

Publication Publication Date Title
MX2007016324A (en) Hcv inhibitors.
TW200635596A (en) Pyridazinone compounds
JO2593B1 (en) HCV NS3 Protease Inhibitors
MY164469A (en) Hcv ns3 protease inhibitors
HK1123733A1 (en) Viral hepatitis treatment
ATE551337T1 (en) HEPATITIS C VIRUS INHIBITORS
SG163517A1 (en) Antiviral compounds and methods
IL196815A0 (en) Hepatitis c virus inhibitors
MX2011006631A (en) Hcv ns3 protease inhibitors.
WO2008057208A3 (en) Hcv ns3 protease inhibitors
WO2008051514A3 (en) Hcv ns3 protease inhibitors
WO2008051475A3 (en) Hcv ns3 protease inhibitors
SI1987038T1 (en) Hcv ns5b inhibitors
MY186633A (en) Heterocyclic compounds as inhibitors of hepatitis c virus (hcv)
MX2011009644A (en) Hepatitis c virus inhibitors.
WO2006119061A3 (en) Hcv ns3 protease inhibitors
MX2009010564A (en) 5,6-dihydro-1h-pyridin-2-one compounds.
UA90909C2 (en) Hcv ns3 protease inhibitors
MX2008001541A (en) Methods for the preparation of hcv polymerase inhibitors.
WO2007005779A3 (en) Antiviral agents
TW200744625A (en) HCV inhibitors
UA95990C2 (en) Hcv ns3 protease inhibitors
TW200716123A (en) Pteridines useful as HCV inhibitors and methods for the preparation thereof

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees